Erratum to: Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates (Nature Biomedical Engineering, (2018), 2, 5, (279-292), 10.1038/s41551-018-0221-2)

Research output: Contribution to journalComment/debateResearchpeer-review

  • Marnix Lameijer
  • Mandy M.T. van Leent
  • Max L. Senders
  • Francois Fay
  • Joost Malkus
  • Brenda L. Sanchez-Gaytan
  • Abraham J.P. Teunissen
  • Nicolas Karakatsanis
  • Philip Robson
  • Xianxiao Zhou
  • Yuxiang Ye
  • Gregory Wojtkiewicz
  • Jun Tang
  • Tom T.P. Seijkens
  • Jeffrey Kroon
  • Erik S.G. Stroes
  • Jordi Ochando
  • Thomas Reiner
  • Carlos Pérez-Medina
  • Claudia Calcagno
  • Edward A. Fisher
  • Bin Zhang
  • Ryan E. Temel
  • Filip K. Swirski
  • Matthias Nahrendorf
  • Zahi A. Fayad
  • Esther Lutgens
  • Willem J.M. Mulder
  • Raphaël Duivenvoorden

In the version of this Article originally published, the surname of the author Edward A. Fisher was spelt incorrectly as ‘Fischer’. This has now been corrected.

Original languageEnglish
JournalNature Biomedical Engineering
Volume2
Issue number8
Pages (from-to)623
Number of pages1
DOIs
Publication statusPublished - 1 Aug 2018

Bibliographical note

Publisher Copyright:
© 2018, The Publisher.

ID: 283514199